{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:28:18Z","timestamp":1793089698166,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T00:00:00Z","timestamp":1279929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10585-010-9345-9","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T10:56:43Z","timestamp":1279882603000},"page":"557-569","source":"Crossref","is-referenced-by-count":84,"title":["Co-expression of CD147\/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression"],"prefix":"10.1007","volume":"27","author":[{"given":"Hongmin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beretov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,24]]},"reference":[{"key":"9345_CR1","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/S0959-8049(03)00619-1","volume":"39","author":"RD Baird","year":"2003","unstructured":"Baird RD, Kaye SB (2003) Drug resistance reversal\u2014are we getting closer? Eur J Cancer 39:2450\u20132561","journal-title":"Eur J Cancer"},{"key":"9345_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1160\/TH04-08-0536","volume":"93","author":"L Yan","year":"2005","unstructured":"Yan L, Zucker S, Toole BP (2005) Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 93:199\u2013204","journal-title":"Thromb Haemost"},{"key":"9345_CR3","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/0008-5472.CAN-06-3184","volume":"67","author":"SM Gallagher","year":"2007","unstructured":"Gallagher SM, Castorino JJ, Wang D, Philp NJ (2007) Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. Cancer Res 67:4182\u20134189","journal-title":"Cancer Res"},{"key":"9345_CR4","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1158\/0008-5472.CAN-08-2491","volume":"69","author":"MG Slomiany","year":"2009","unstructured":"Slomiany MG, Grass GD, Robertson AD, Yang XY, Maria BL, Beeson C, Toole BP (2009) Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells. Cancer Res 69:1293\u20131301","journal-title":"Cancer Res"},{"key":"9345_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF00121214","volume":"14","author":"R Martinez-Zaguilan","year":"1996","unstructured":"Martinez-Zaguilan R, Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ (1996) Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis 14:176\u2013186","journal-title":"Clin Exp Metastasis"},{"key":"9345_CR6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tredan","year":"2007","unstructured":"Tredan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99:1441\u20131454","journal-title":"J Natl Cancer Inst"},{"key":"9345_CR7","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1124\/mol.106.026245","volume":"70","author":"J Fang","year":"2006","unstructured":"Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML (2006) The H+-linked monocarboxylate transporter (MCT1\/SLC16A1): a potential therapeutic target for high-risk neuroblastoma. Mol Pharmacol 70:2108\u20132115","journal-title":"Mol Pharmacol"},{"key":"9345_CR8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001756-200103260-00030","volume":"12","author":"MK Froberg","year":"2001","unstructured":"Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, Seacotte N, Drewes LR (2001) Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 12:761\u2013765","journal-title":"Neuroreport"},{"key":"9345_CR9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1158\/0008-5472.CAN-05-3144","volume":"66","author":"MI Koukourakis","year":"2006","unstructured":"Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E (2006) Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 66:627\u2013632","journal-title":"Cancer Res"},{"key":"9345_CR10","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","volume":"19","author":"P Kirk","year":"2000","unstructured":"Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP (2000) CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 19:3896\u20133904","journal-title":"EMBO J"},{"key":"9345_CR11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0959-8049(96)00057-3","volume":"32A","author":"UA Germann","year":"1996","unstructured":"Germann UA (1996) P-glycoprotein\u2014a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A:927\u2013944","journal-title":"Eur J Cancer"},{"key":"9345_CR12","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1038\/sj.onc.1206953","volume":"22","author":"GD Kruh","year":"2003","unstructured":"Kruh GD, Belinsky MG (2003) The MRP family of drug efflux pumps. Oncogene 22:7537\u20137752","journal-title":"Oncogene"},{"key":"9345_CR13","first-page":"3537","volume":"57","author":"M Kool","year":"1997","unstructured":"Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537\u20133547","journal-title":"Cancer Res"},{"key":"9345_CR14","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1158\/1078-0432.CCR-06-0564","volume":"12","author":"P Surowiak","year":"2006","unstructured":"Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dolinska-Krajewska B, Gebarowska E, Dietel M, Zabel M, Lage H (2006) ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. Clin Cancer Res 12:7149\u20137158","journal-title":"Clin Cancer Res"},{"key":"9345_CR15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4161\/cbt.6.6.4190","volume":"6","author":"H Yang","year":"2007","unstructured":"Yang H, Zou W, Li Y, Chen B, Xin X (2007) Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells. Cancer Biol Ther 6:942\u2013947","journal-title":"Cancer Biol Ther"},{"key":"9345_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2008.07.034","volume":"273","author":"J Su","year":"2009","unstructured":"Su J, Chen X, Kanekura T (2009) A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 273:140\u2013147","journal-title":"Cancer Lett"},{"key":"9345_CR17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/gut.2009.181412","volume":"58","author":"W Schneiderhan","year":"2009","unstructured":"Schneiderhan W, Scheler M, Holzmann KH, Marx M, Gschwend JE, Bucholz M, Gress TM, Seufferlein T, Adler G, Oswald F (2009) CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 58:1391\u20131398","journal-title":"Gut"},{"key":"9345_CR18","first-page":"125","volume":"5","author":"WJ Creasman","year":"1998","unstructured":"Creasman WJ (1998) Announcement, FIGO stages: 1988 revisions. Gynecol Oncol 5:125\u2013127","journal-title":"Gynecol Oncol"},{"key":"9345_CR19","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.1073\/pnas.0504419102","volume":"102","author":"AA Deora","year":"2005","unstructured":"Deora AA, Philp N, Hu J, Bok D, Rodriguez-Boulan E (2005) Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. Proc Natl Acad Sci USA 102:16245\u201316250","journal-title":"Proc Natl Acad Sci USA"},{"key":"9345_CR20","doi-asserted-by":"crossref","first-page":"20310","DOI":"10.1074\/jbc.M500737200","volume":"280","author":"S Misra","year":"2005","unstructured":"Misra S, Ghatak S, Toole BP (2005) Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 280:20310\u201320315","journal-title":"J Biol Chem"},{"key":"9345_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2006.07.005","volume":"248","author":"W Zou","year":"2007","unstructured":"Zou W, Yang H, Hou X, Zhang W, Chen B, Xin X (2007) Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Lett 248:211\u2013218","journal-title":"Cancer Lett"},{"key":"9345_CR22","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1021\/pr800355b","volume":"7","author":"YH Kuang","year":"2008","unstructured":"Kuang YH, Chen X, Su J, Wu LS, Li J, Chang J, Qiu Y, Chen ZS, Kanekura T (2008) Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing. J Proteome Res 7:4784\u20134791","journal-title":"J Proteome Res"},{"key":"9345_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00277-008-0678-2","volume":"88","author":"L Jia","year":"2009","unstructured":"Jia L, Wei W, Cao J, Xu H, Miao X, Zhang J (2009) Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells. Ann Hematol 88:753\u2013760","journal-title":"Ann Hematol"},{"key":"9345_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1022696012668","volume":"20","author":"B Davidson","year":"2003","unstructured":"Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R (2003) EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 20:161\u2013169","journal-title":"Clin Exp Metastasis"},{"key":"9345_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1593\/neo.07133","volume":"9","author":"D Millimaggi","year":"2007","unstructured":"Millimaggi D, Mari M, D\u2019Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V (2007) Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9:349\u2013357","journal-title":"Neoplasia"},{"key":"9345_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.pgp.0000189244.57145.84","volume":"25","author":"JS Jin","year":"2006","unstructured":"Jin JS, Yao CW, Loh SH, Cheng MF, Hsieh DS, Bai CY (2006) Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters. Int J Gynecol Pathol 25:140\u2013146","journal-title":"Int J Gynecol Pathol"},{"key":"9345_CR27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000110426","volume":"28","author":"S Sillanpaa","year":"2007","unstructured":"Sillanpaa S, Anttila M, Suhonen K, Hamalainen K, Turpeenniemi-Hujanen T, Puistola U, Tammi M, Sironen R, Saarikoski S, Kosma VM (2007) Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol 28:280\u2013289","journal-title":"Tumour Biol"},{"key":"9345_CR28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891\u2013899","journal-title":"Nat Rev Cancer"},{"key":"9345_CR29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0305-7372(03)00106-3","volume":"29","author":"H Izumi","year":"2003","unstructured":"Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M, Ise T, Murakami T, Yoshida T, Nomoto M, Kohno K (2003) Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev 29:541\u2013549","journal-title":"Cancer Treat Rev"},{"key":"9345_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","volume":"452","author":"C Pinheiro","year":"2008","unstructured":"Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F, Baltazar F (2008) Increased expression of monocarboxylate transporters 1, 2 and 4 in colorectal carcinomas. Virchows Arch 452:139\u2013146","journal-title":"Virchows Arch"},{"key":"9345_CR31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0b013e31817b5b40","volume":"27","author":"C Pinheiro","year":"2008","unstructured":"Pinheiro C, Longatto-Filho A, Ferreira L, Pereira SM, Etlinger D, Moreira MA, Jube LF, Queiroz GS, Schmitt F, Baltazar F (2008) Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int J Gynecol Pathol 27:568\u2013574","journal-title":"Int J Gynecol Pathol"},{"key":"9345_CR32","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4161\/cbt.6.9.4635","volume":"6","author":"MI Koukourakis","year":"2007","unstructured":"Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E (2007) Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther 6:1476\u20131479","journal-title":"Cancer Biol Ther"},{"key":"9345_CR33","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2009.06.018","volume":"45","author":"C Pinheiro","year":"2009","unstructured":"Pinheiro C, Longatto-Filho A, Simoes K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F (2009) The prognostic value of CD147\/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Euro J Cancer 45:2418\u20132424","journal-title":"Euro J Cancer"},{"key":"9345_CR34","first-page":"117","volume":"17","author":"H Xing","year":"2007","unstructured":"Xing H, Wang S, Weng D, Chen G, Yang X, Zhou J, Xu G, Lu Y, Ma D (2007) Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. Oncol Reports 17:117\u2013122","journal-title":"Oncol Reports"},{"key":"9345_CR35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2003.11.053","volume":"93","author":"RT Penson","year":"2004","unstructured":"Penson RT, Oliva E, Skates SJ, Glyptis T, Fuller AF Jr, Goodman A, Seiden MV (2004) Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol 93:98\u2013106","journal-title":"Gynecol Oncol"},{"key":"9345_CR36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2004.03.035","volume":"94","author":"V Materna","year":"2004","unstructured":"Materna V, Pleger J, Hoffmann U, Lage H (2004) RNA expression of MDR1\/P-glycoprotein, DNA-topoisomerase I, trans and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response. Gynecol Oncol 94:152\u2013160","journal-title":"Gynecol Oncol"},{"key":"9345_CR37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1447-0756.1999.tb01182.x","volume":"25","author":"Y Yokoyama","year":"1999","unstructured":"Yokoyama Y, Sato S, Fukushi Y, Sakamoto T, Futagami M, Saito Y (1999) Significance of multi-drug-resistant proteins in predicting chemotherapy response and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res 25:387\u2013394","journal-title":"J Obstet Gynaecol Res"},{"key":"9345_CR38","first-page":"337","volume":"23","author":"SS Ozalp","year":"2002","unstructured":"Ozalp SS, Yalcin OT, Tanir M, Kabukcuoglu S, Etiz E (2002) Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies. Eur J Gynaecol Oncol 23:337\u2013340","journal-title":"Eur J Gynaecol Oncol"},{"key":"9345_CR39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.bjc.6605185","volume":"101","author":"H Chen","year":"2009","unstructured":"Chen H, Hao JL, Wang L, Li Y (2009) Coexpression of invasive markers (uPA, CD44) and multiple drug resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression. Br J Cancer 101:432\u2013440","journal-title":"Br J Cancer"},{"key":"9345_CR40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.20899","volume":"115","author":"V Materna","year":"2005","unstructured":"Materna V, Liedert B, Thomale J, Lage H (2005) Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells. Int J Cancer 115:393\u2013402","journal-title":"Int J Cancer"},{"key":"9345_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00404-008-0690-8","volume":"279","author":"JJ Ma","year":"2009","unstructured":"Ma JJ, Chen BL, Xin XY (2009) Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene. Arch Gynecol Obstet 279:149\u2013157","journal-title":"Arch Gynecol Obstet"},{"key":"9345_CR42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/1541-7786.MCR-06-0286","volume":"5","author":"J Xu","year":"2007","unstructured":"Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM, Mi L, Wen N, Tian R, Wang L, Yao H, Feng Q, Zhang Y, Xing JL, Zhu P, Chen ZN (2007) HAb18G\/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 5:605\u2013614","journal-title":"Mol Cancer Res"},{"key":"9345_CR43","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1158\/1078-0432.CCR-09-0212","volume":"15","author":"NR Dean","year":"2009","unstructured":"Dean NR, Newman JR, Helman EE, Zhang W, Safavy S, Weeks DM, Cunningham M, Snyder LA, Tang Y, Yan L, McNally LR, Buchsbaum DJ, Rosenthal EL (2009) Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res 15:4058\u20134065","journal-title":"Clin Cancer Res"},{"key":"9345_CR44","first-page":"77","volume":"36","author":"H Matsudaira","year":"2010","unstructured":"Matsudaira H, Asakura T, Aoki K, Searashi Y, Matsuura T, Nakajima H, Tajiri H, Ohkawa K (2010) Target chemotherapy of anti-CD147 antibody-labeled liposome encapsulated GSH-DXR conjugate on CD147 highly expressed carcinoma cells. Int J Oncol 36:77\u201383","journal-title":"Int J Oncol"},{"key":"9345_CR45","first-page":"3930","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930\u20133942","journal-title":"J Clin Invest"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-010-9345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-010-9345-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-010-9345-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:55:13Z","timestamp":1559296513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-010-9345-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,24]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9345"],"URL":"https:\/\/doi.org\/10.1007\/s10585-010-9345-9","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,24]]}}}